Company: PSTV
Filing Date: 2025-07-21
Form Type: DEF 14A
Source: 0001140361-25-026611
Chunk: 55

Company: PLUS THERAPEUTICS, INC.
Filing Date: 2025-07-21
Form: DEF 14A
Chunk 55
---
 forth the aggregate number of Private Placement Shares and Warrants purchased by the Company Insiders in the May 2024 PIPE Financing:

| Name                     |     | Number of Private 
  Placement Shares |     | Number of      
 Pre-Funded     
 Warrant Shares |     |        Number of 
 Series A Warrant 
           Shares |     |        Number of 
 Series B Warrant 
           Shares |     |  Aggregate 
   Purchase 
      Price 
        ($) |
| Marc H. Hedrick, M.D.(1) |     |            12,255 |     | —              |     |           12,255 |     |           12,255 |     |  25,000.20 |
| Andrew Sims(2)           |     |             4,902 |     | —              |     |            4,902 |     |            4,902 |     |  10,000.08 |
| Richard J. Hawkins(3)    |     |             4,902 |     | —              |     |            4,902 |     |            4,902 |     |  10,000.08 |
| Howard Clowes(4)         |     |             9,804 |     | —              |     |            9,804 |     |            9,804 |     |  20,000.16 |
| Robert Lenk, Ph.D.(5)    |     |             4,167 |     | —              |     |            4,167 |     |            4,167 |     |   8,500.16 |
| Greg Petersen(6)         |     |            12,255 |     | —              |     |           12,255 |     |           12,255 |     |  25,000.20 |
| Total:                   |     |            48,285 |     | —              |     |           48,285 |     |           48,285 |     | $98,500.88 |

| (1) | Marc H. Hedrick, M.D. serves as the Company’s President, Chief Executive Officer and a member of our Board. |

| (2) | Andrew Sims is our Chief Financial Officer. |

| (3) | Mr. Hawkins serves as the Chairman of our Board. |

| (4) | Mr. Clowes is a member of our